Gapping up
In reaction to earnings/guidance:
- ACB +22%, RETA +19%, CGC +8.9%, MIC +7.8%, EBIX +7.5%, ICPT +6.6%, BRK.B +5.5%, MCD +4.8%, BCOR +4.7%, PLUG +2.7%, TGNA +2.5%, GOGO +2.3%, ITCI +2.2%, RDNT +2%, ALE +2%, BKI +2%
Select ETFs showing strength:
- XLE +11.8%, IWM +7.4%, XLI +7.3%, XLF +6.7%, DIA +5.4%, XLB +5.2%, SPY +4.3%, XLV +3.4%, XLK +1.2%, .
Other news:
- CALT +50.9% (reports topline results from pivotal Phase 3 NefIgArd trial met primary endpoint)
- BNTX +23.4% (Pfizer and BioNTech announce vaccine candidate against COVID-19 achieved success in first interim analysis from Phase 3 study)
- PFE +12.4% (Pfizer and BioNTech (BNTX) announce vaccine candidate against COVID-19 achieved success in first interim analysis from Phase 3 study)
- FFIV +10.8% (announces $1 bln in total share repurchases across fiscal years 2021 and 2022 and intention to return 50% of free cash flow thereafter; details long term targets)
- CNTG +7.3% (Centogene and Fujirebio Europe enter partnership to provide rapid and high-quality preventive SARS-CoV-2 Antigen Testing)
- ARCO +5.5% (released letter with shareholder updates)
- CMPS +4.9% (joins the Psychiatry Consortium in a collaboration to accelerate drug discovery in mental health care)
- LMNL +4.1% (reports PDUFA date extended by FDA from March 5, 2021 to June 5)
- GPRO +3.4% (D.E. Shaw increased passive stake to 5.0%)
- GSK +2.9% (GlaxoSmithKline and Pfizer report their ViiV Healthcare investigational injectable cabotegravir is superior to oral standard of care for HIV prevention in women)
- TSN +2% (Tyson Foods announced the European launch of its plant-based protein brand, Raised & Rooted) .
Analyst comments:
- FTI +15.5% (upgraded to Buy from Hold at HSBC Securities)
- JWN +15.2% (upgraded to Outperform from Market Perform at Telsey Advisory Group)
- RDS.A +11.2% (upgraded to Buy from Hold at HSBC Securities)
- CAKE +11.1% (upgraded to Buy from Hold at Deutsche Bank)
- LTHM +8.1% (upgraded to Buy from Neutral at Citigroup)
- ARQT +6.8% (upgraded to Buy from Neutral at Goldman)
- TCS +5.1% (upgraded to Neutral from Sell at Goldman)
- YELP +4.9% (upgraded to Neutral from Sell at UBS)
- RPRX +4.7% (upgraded to Buy from Neutral at UBS)
- SNDR +4.1% (upgraded to Buy from Hold at Stifel)
- VSTO +3.8% (upgraded to Overweight from Sector Weight at KeyBanc Capital Markets)